For research use only. Not for therapeutic Use.
Enalapril Diketopiperazine (Cat.No:R054449) is a metabolite of enalapril, an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and heart failure. It forms in the body from enalapril hydrolysis. Its relevance lies in understanding the pharmacokinetics and metabolism of enalapril, contributing to better drug efficacy and safety assessment.
Catalog Number | R054449 |
CAS Number | 115729-52-7 |
Synonyms | (αS,3S,8aS)-Hexahydro-3-methyl-1,4-dioxo-α-(2-phenylethyl)pyrrolo[1,2-a]pyrazine-2(1H)-acetic Acid Ethyl Ester; [3S-[2(R*),3α,8aβ]]-Hexahydro-3-methyl-1,4-dioxo-α-(2-phenylethyl)pyrrolo[1,2-a]pyrazine-2(1H)-acetic Acid Ethyl Ester; Enalapril DKP; |
Molecular Formula | C20H26N2O4 |
Purity | ≥95% |
Storage | Desiccate at RT |
IUPAC Name | ethyl (2S)-2-[(3S,8aS)-3-methyl-1,4-dioxo-6,7,8,8a-tetrahydro-3H-pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate |
InChI | InChI=1S/C20H26N2O4/c1-3-26-20(25)17(12-11-15-8-5-4-6-9-15)22-14(2)18(23)21-13-7-10-16(21)19(22)24/h4-6,8-9,14,16-17H,3,7,10-13H2,1-2H3/t14-,16-,17-/m0/s1 |
InChIKey | BMZHNHHJUGMMLV-XIRDDKMYSA-N |
SMILES | CCOC(=O)C(CCC1=CC=CC=C1)N2C(C(=O)N3CCCC3C2=O)C |
Reference | <p> |